Preclinical proof of concept for the first [18F]-Nanocyclix®TKI-PET radiotracer targeting activated EGFR positive lung tumors

C Berthet , O Raguin , S Chalon , X Tizon , S Serrière , P Provent , M Hillairet de Boisferoni , G Serini , J Vercouillie , C Mothes , F Gourand (1) , L Barré (1) , D Guilloteau , P Blom , J Hoflack , P. Genne

1 ISTCT - Imagerie et Stratégies Thérapeutiques des pathologies Cérébrales et Tumorales

Domains: Life Sciences [q-bio]; Chemical Sciences; Chemical Sciences; Radiochemistry

C Berthet, O Raguin, S Chalon, X Tizon, S Serrière, et al.. Preclinical proof of concept for the first [18F]-Nanocyclix®TKI-PET radiotracer targeting activated EGFR positive lung tumors. American Association for Cancer Research, Apr 2017, Washington, France. ⟨hal-02386511⟩